Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Deretil

Deretil?uq=PEM9b6PF
1961 FOUNDED
M&A STATUS
101-200 EMPLOYEES
M&A LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Developer, manufacturer and seller of raw materials for beta-lactam antibiotics. The company operates production plants and is engaged in the production and distribution of pharmaceutical raw material and antibiotics, it also provides services like research and development, production, quality assurance and quality control, integrated management systems, staff training, logistics and other customer services

Website
Formerly Known As
Derivados del Etilio, DSM Deretil
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 161 La Llacuna Street, 2nd floor
  • 08018 Barcelona
  • Spain

+34 934 00 00 00

Deretil Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Deretil‘s full profile, request access.

Request full access to PitchBook

Deretil Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Deretil‘s full profile, request access.

Request full access to PitchBook

Deretil Executive Team (1)

Name Title Board
Seat
Contact
Info
Lluis Franquesa President & General Manager